BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Xenome Ltd 

120 Meiers Road

Indooroopilly  Queensland  4068  Australia
Phone: 61-7-3720-8055 Fax: 61-7-3720-8388


SEARCH JOBS


Industry
Biotechnology






 Company News
Xenome Ltd's Hopes for Painkiller Hit Trouble, Considers Partners for New Strategy 8/19/2013 8:02:18 AM    More...
Biopharmaceutical Company Xenome Ltd Today Announced The Appointment Of Michael Aldridge As Executive Director 5/25/2010 1:38:25 PM    More...
Xenome Ltd Licenses Peptides from xdiscoverTM Library to MedImmune 3/23/2010 2:23:23 PM    More...
Dr Julie Cherrington Joins Xenome Ltd Board 8/11/2009 12:07:26 PM    More...
Xenome Ltd And Axxam srl Initiate Discovery Partnership Focused On Novel Peptides Against GPCR Targets 8/11/2009 12:05:16 PM    More...
Xenome Ltd Release: Addition To US Patent Portfolio For Xen2174 4/23/2009 3:03:25 PM    More...
Xenome Ltd Grants MedImmune License to xdiscover(TM) Venom Peptide Library 1/8/2009 11:39:32 AM    More...
Xenome Ltd Initiates Phase II Clinical Trial Of Xen2174 In Acute Pain 9/26/2008 2:55:56 PM    More...
Xenome Ltd Presents Xen2174 Data on Relief of Pain in Cancer Patients 8/21/2008 7:50:44 AM    More...
Leading Bioscience Fund GBS Invests $6 Million in Xenome Ltd 7/23/2008 6:51:15 AM    More...
123

//-->